Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | EO1428 | 1.0 | uM | 1 | MCP3 | 28.0 | 76 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | MCP3 | 239.0 | 33 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | MCP3 | 180.0 | 47 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MCP3 | 170.5 | 40 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MCP3 | 240.5 | 58 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MCP3 | 270.0 | 66 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | MCP3 | 276.5 | 40 | |
N2586 | EO1428 | 1.0 | uM | 1 | MCP3 | 57.0 | 61 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 158.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 63.0 | 61 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 70.5 | 42 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 128.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 111.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 30.0 | 70 | |
RA2159 | PI103 | 0.1 | uM | 1 | MCP3 | 29.0 | 63 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 666.5 | 56 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 272.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 357.0 | 53 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 778.0 | 61 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 697.0 | 57 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP3 | 157.0 | 41 | |
N2586 | PI103 | 0.1 | uM | 1 | MCP3 | 49.5 | 40 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | MCP3 | 28.0 | 66 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 25.0 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 28.0 | 69 |